First Time Loading...

Sera Prognostics Inc
NASDAQ:SERA

Watchlist Manager
Sera Prognostics Inc Logo
Sera Prognostics Inc
NASDAQ:SERA
Watchlist
Price: 9.72 USD -0.72%
Updated: Apr 19, 2024

Intrinsic Value

SERA's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. [ Read More ]

The intrinsic value of one SERA stock under the Base Case scenario is 4.43 USD. Compared to the current market price of 9.72 USD, Sera Prognostics Inc is Overvalued by 54%.

Key Points:
SERA Intrinsic Value
Base Case
4.43 USD
Overvaluation 54%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Sera Prognostics Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling SERA stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Sera Prognostics Inc

Provide an overview of the primary business activities
of Sera Prognostics Inc.

What unique competitive advantages
does Sera Prognostics Inc hold over its rivals?

What risks and challenges
does Sera Prognostics Inc face in the near future?

Has there been any significant insider trading activity
in Sera Prognostics Inc recently?

Summarize the latest earnings call
of Sera Prognostics Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Sera Prognostics Inc.

Provide P/S
for Sera Prognostics Inc.

Provide P/E
for Sera Prognostics Inc.

Provide P/OCF
for Sera Prognostics Inc.

Provide P/FCFE
for Sera Prognostics Inc.

Provide P/B
for Sera Prognostics Inc.

Provide EV/S
for Sera Prognostics Inc.

Provide EV/GP
for Sera Prognostics Inc.

Provide EV/EBITDA
for Sera Prognostics Inc.

Provide EV/EBIT
for Sera Prognostics Inc.

Provide EV/OCF
for Sera Prognostics Inc.

Provide EV/FCFF
for Sera Prognostics Inc.

Provide EV/IC
for Sera Prognostics Inc.

Show me price targets
for Sera Prognostics Inc made by professional analysts.

What are the Revenue projections
for Sera Prognostics Inc?

How accurate were the past Revenue estimates
for Sera Prognostics Inc?

What are the Net Income projections
for Sera Prognostics Inc?

How accurate were the past Net Income estimates
for Sera Prognostics Inc?

What are the EPS projections
for Sera Prognostics Inc?

How accurate were the past EPS estimates
for Sera Prognostics Inc?

What are the EBIT projections
for Sera Prognostics Inc?

How accurate were the past EBIT estimates
for Sera Prognostics Inc?

Compare the revenue forecasts
for Sera Prognostics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Sera Prognostics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Sera Prognostics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Sera Prognostics Inc compared to its peers.

Compare the P/E ratios
of Sera Prognostics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Sera Prognostics Inc with its peers.

Analyze the financial leverage
of Sera Prognostics Inc compared to its main competitors.

Show all profitability ratios
for Sera Prognostics Inc.

Provide ROE
for Sera Prognostics Inc.

Provide ROA
for Sera Prognostics Inc.

Provide ROIC
for Sera Prognostics Inc.

Provide ROCE
for Sera Prognostics Inc.

Provide Gross Margin
for Sera Prognostics Inc.

Provide Operating Margin
for Sera Prognostics Inc.

Provide Net Margin
for Sera Prognostics Inc.

Provide FCF Margin
for Sera Prognostics Inc.

Show all solvency ratios
for Sera Prognostics Inc.

Provide D/E Ratio
for Sera Prognostics Inc.

Provide D/A Ratio
for Sera Prognostics Inc.

Provide Interest Coverage Ratio
for Sera Prognostics Inc.

Provide Altman Z-Score Ratio
for Sera Prognostics Inc.

Provide Quick Ratio
for Sera Prognostics Inc.

Provide Current Ratio
for Sera Prognostics Inc.

Provide Cash Ratio
for Sera Prognostics Inc.

What is the historical Revenue growth
over the last 5 years for Sera Prognostics Inc?

What is the historical Net Income growth
over the last 5 years for Sera Prognostics Inc?

What is the current Free Cash Flow
of Sera Prognostics Inc?

Financials

Balance Sheet Decomposition
Sera Prognostics Inc

Current Assets 61.3m
Cash & Short-Term Investments 49.1m
Receivables 11.5m
Other Current Assets 795k
Non-Current Assets 34.1m
Long-Term Investments 30.8m
PP&E 3.2m
Other Non-Current Assets 77k
Current Liabilities 24.4m
Accounts Payable 1m
Accrued Liabilities 1.8m
Other Current Liabilities 21.6m
Non-Current Liabilities 840k
Long-Term Debt 196k
Other Non-Current Liabilities 644k
Efficiency

Earnings Waterfall
Sera Prognostics Inc

Revenue
306k USD
Cost of Revenue
-210k USD
Gross Profit
96k USD
Operating Expenses
-39.9m USD
Operating Income
-39.8m USD
Other Expenses
3.6m USD
Net Income
-36.2m USD

Free Cash Flow Analysis
Sera Prognostics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

SERA Profitability Score
Profitability Due Diligence

Sera Prognostics Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional Revenue Growth Forecast
Positive Gross Profit
ROIC is Increasing
32/100
Profitability
Score

Sera Prognostics Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

SERA Solvency Score
Solvency Due Diligence

Sera Prognostics Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
51/100
Solvency
Score

Sera Prognostics Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SERA Price Targets Summary
Sera Prognostics Inc

Wall Street analysts forecast SERA stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SERA is 2.75 USD .

Lowest
Price Target
Not Available
Average
Price Target
2.75 USD
72% Downside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

SERA Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

SERA Price
Sera Prognostics Inc

1M 1M
+7%
6M 6M
+455%
1Y 1Y
+190%
3Y 3Y
-18%
5Y 5Y
-18%
10Y 10Y
-18%
Annual Price Range
9.72
52w Low
1.55
52w High
11.25
Price Metrics
Average Annual Return -59.24%
Standard Deviation of Annual Returns 33.5%
Max Drawdown -91%
Shares Statistics
Market Capitalization 310.4m USD
Shares Outstanding 32 430 000
Percentage of Shares Shorted 0.8%

SERA Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Sera Prognostics Inc Logo
Sera Prognostics Inc

Country

United States of America

Industry

Biotechnology

Market Cap

310.4m USD

Dividend Yield

0%

Description

Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. The company is headquartered in Salt Lake City, Utah and currently employs 115 full-time employees. The company went IPO on 2021-07-15. The company has built a proteomics and bioinformatics platform to characterize the biology of pregnancy and to discover and validate key protein biomarkers found in blood that are accurate predictors of dynamic changes that occur during pregnancy. The firm's commercial product, the PreTRM test, is a blood-based biomarker test to accurately predict the risk of a premature delivery, also known as preterm birth. The PreTRM test is a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 19 or 20 of gestation. Its biomarker pregnancy pipeline includes preeclampsia, molecular time-to-birth, gestational diabetes mellitus (GDM), fetal growth restriction, stillbirth and postpartum depression.

Contact

UTAH
Salt Lake City
2749 E. Parleys Way, Suite 200
+18019900520.0
https://www.seraprognostics.com/

IPO

2021-07-15

Employees

115

Officers

President, CEO & Director
Ms. Evguenia Lindgardt M.B.A.
Executive Director
Dr. Gregory C. Critchfield M.D., M.S.
Co-Founder and Co-Chairman of The Scientific Advisory Board
Dr. Steven W. Graves
Co-Founder and Co-Chairman of Scientific Advisory Board
Dr. M. Sean Esplin M.D.
Chief Financial Officer??
Mr. Austin Aerts
Chief Scientific Officer
Dr. John J. Boniface Ph.D.
Show More
Chief Information Officer
Mr. Robert G. Harrison
General Counsel
Mr. Benjamin G. Jackson J.D.
Chief Data Officer
Dr. Paul Kearney Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one SERA stock?

The intrinsic value of one SERA stock under the Base Case scenario is 4.43 USD.

Is SERA stock undervalued or overvalued?

Compared to the current market price of 9.72 USD, Sera Prognostics Inc is Overvalued by 54%.